They found that differences in bulk expression profiles between IDH-A and IDH-O were explained primarily by genetic alterations and the composition of the tumor microenvironment (TME), but not by distinct glial expression programs in the malignant cells. The gene discussed is IDH1; the disease is neoplasm.